From: Prognostic value of anti-CRP antibodies in lupus nephritis in long-term follow-up
Age (years) | 32 (21.7–62.4) | |
Gender, male/female | 10/47 | |
Caucasian/Asian | 55 (96.5 %)/ 2 (3.5 %) | |
Renal disease duration (days) | 75 (1–2413) | |
Renal biopsy | Class II | 2 (3.5 %) |
Class III | 13 (22.8 %) | |
Class IV | 28 (49.1 %) | |
Class III/V or IV/V | 11 (19.3 %) | |
Undetermined class | 3 (5.3 %) |